{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:35:18Z","timestamp":1776954918823,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,16]]},"DOI":"10.7759\/cureus.17208","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T09:15:40Z","timestamp":1629105340000},"source":"Crossref","is-referenced-by-count":7,"title":["Paired-Box Gene 8 (PAX8) and Its Association With Epithelial Carcinomas"],"prefix":"10.7759","author":[{"given":"Khalid","family":"Khizer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaskamal","family":"Padda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwar","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahriba","family":"Tasnim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola A","family":"Al-Ewaidat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Yosef Melt","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gutteridge","family":"Jean-Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"An Update on Cancer Deaths in the United States. (2021). Accessed. June 14, 2021: http:\/\/www.cdc.gov\/cancer\/dcpc\/research\/update-on-cancer-deaths\/index.htm."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel RL","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020, 70:7-30. 10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2013.11.003","article-title":"Changes in cell and tissue organization in cancer of the breast and colon","volume":"26","author":"Hinck L","year":"2014","unstructured":"Hinck L, N\u00e4thke I. Changes in cell and tissue organization in cancer of the breast and colon. Curr Opin Cell Biol. 2014, 26:87-95. 10.1016\/j.ceb.2013.11.003","journal-title":"Curr Opin Cell Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.06.024","article-title":"PAX genes: roles in development, pathophysiology, and cancer","volume":"73","author":"Lang D","year":"2007","unstructured":"Lang D, Powell SK, Plummer RS, Young KP, Ruggeri BA. PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol. 2007, 73:1-14. 10.1016\/j.bcp.2006.06.024","journal-title":"Biochem Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0955-0674(96)80087-1","article-title":"Pax genes and their roles in cell differentiation and development","volume":"8","author":"Mansouri A","year":"1996","unstructured":"Mansouri A, Hallonet M, Gruss P. Pax genes and their roles in cell differentiation and development. Curr Opin Cell Biol. 1996, 8:851-57. 10.1016\/s0955-0674(96)80087-1","journal-title":"Curr Opin Cell Biol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1242\/dev.110.2.643","article-title":"Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland","volume":"110","author":"Plachov D","year":"1990","unstructured":"Plachov D, Chowdhury K, Walther C, Simon D, Guenet JL, Gruss P. Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. Development. 1990, 110:643-51.","journal-title":"Development"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.88","article-title":"Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study","volume":"22","author":"Tong GX","year":"2009","unstructured":"Tong GX, Yu WM, Beaubier NT, Weeden EM, Hamele-Bena D, Mansukhani MM, O'Toole KM. Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod Pathol. 2009, 22:1218-27. 10.1038\/modpathol.2009.88","journal-title":"Mod Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3801002","article-title":"Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms","volume":"21","author":"Nonaka D","year":"2008","unstructured":"Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol. 2008, 21:192-200. 10.1038\/modpathol.3801002","journal-title":"Mod Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen NJ","year":"2007","unstructured":"Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, McDonald JF. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2007, 104:331-37. 10.1016\/j.ygyno.2006.08.052","journal-title":"Gynecol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury AR","year":"2010","unstructured":"Laury AR, Hornick JL, Perets R, Krane JF, Corson J, Drapkin R, Hirsch MS. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010, 34:627-35. 10.1097\/PAS.0b013e3181da7687","journal-title":"Am J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181962dcd","article-title":"Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma","volume":"33","author":"Lotan TL","year":"2009","unstructured":"Lotan TL, Ye H, Melamed J, Wu XR, Shih Ie-M, Epstein JI. Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma. Am J Surg Pathol. 2009, 33:1037-41. 10.1097\/PAS.0b013e3181962dcd","journal-title":"Am J Surg Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka D","year":"2008","unstructured":"Nonaka D, Chiriboga L, Soslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol. 2008, 32:1566-71. 10.1097\/PAS.0b013e31816d71ad","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury AR","year":"2011","unstructured":"Laury AR, Perets R, Piao H, et al.. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol. 2011, 35:816-26. 10.1097\/PAS.0b013e318216c112","journal-title":"Am J Surg Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3109\/10520295.2011.591838","article-title":"Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung","volume":"87","author":"Ye J","year":"2012","unstructured":"Ye J, Hameed O, Findeis-Hosey JJ, et al.. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung. Biotech Histochem. 2012, 87:30-34. 10.3109\/10520295.2011.591838","journal-title":"Biotech Histochem"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1242\/dev.091785","article-title":"Pax genes: regulators of lineage specification and progenitor cell maintenance","volume":"141","author":"Blake JA","year":"2014","unstructured":"Blake JA, Ziman MR. Pax genes: regulators of lineage specification and progenitor cell maintenance. Development. 2014, 141:737-51. 10.1242\/dev.091785","journal-title":"Development"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.186","article-title":"Thyroid transcription factors in development, differentiation and disease","volume":"11","author":"Fern\u00e1ndez LP","year":"2015","unstructured":"Fern\u00e1ndez LP, L\u00f3pez-M\u00e1rquez A, Santisteban P. Thyroid transcription factors in development, differentiation and disease. Nat Rev Endocrinol. 2015, 11:29-42. 10.1038\/nrendo.2014.186","journal-title":"Nat Rev Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2015.09.016","article-title":"Pax genes in renal development, disease and regeneration","volume":"44","author":"Sharma R","year":"2015","unstructured":"Sharma R, Sanchez-Ferras O, Bouchard M. Pax genes in renal development, disease and regeneration. Semin Cell Dev Biol. 2015, 44:97-106. 10.1016\/j.semcdb.2015.09.016","journal-title":"Semin Cell Dev Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.024158","article-title":"Genetics of congenital hypothyroidism","volume":"42","author":"Park SM","year":"2005","unstructured":"Park SM, Chatterjee VK. Genetics of congenital hypothyroidism. J Med Genet. 2005, 42:379-89. 10.1136\/jmg.2004.024158","journal-title":"J Med Genet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/ng0598-83","article-title":"PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis","volume":"19","author":"Macchia PE","year":"1998","unstructured":"Macchia PE, Lapi P, Krude H, et al.. PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet. 1998, 19:83-86. 10.1038\/ng0598-83","journal-title":"Nat Genet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.262","article-title":"Pax8 has a critical role in epithelial cell survival and proliferation","volume":"4","author":"Di Palma T","year":"2013","unstructured":"Di Palma T, Filippone MG, Pierantoni GM, et al.. Pax8 has a critical role in epithelial cell survival and proliferation. Cell Death Dis. 2013, 4:729-29. 10.1038\/cddis.2013.262","journal-title":"Cell Death Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1121","article-title":"PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas","volume":"5","author":"Xiang L","year":"2013","unstructured":"Xiang L, Kong B. PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas. Oncol Lett. 2013, 5:735-38. 10.3892\/ol.2013.1121","journal-title":"Oncol Lett"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/672829","article-title":"The role of the PAX8\/PPAR\u03b3 fusion oncogene in thyroid cancer","volume":"2008","author":"Placzkowski KA","year":"2008","unstructured":"Placzkowski KA, Reddi HV, Grebe SK, Eberhardt NL, McIver B. The role of the PAX8\/PPAR\u03b3 fusion oncogene in thyroid cancer. PPAR Res. 2008, 2008:672829. 10.1155\/2008\/672829","journal-title":"PPAR Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007%2Fs001250051268","article-title":"PPARgamma, the ultimate thrifty gene","volume":"42","author":"Auwerx J","year":"1999","unstructured":"Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia. 1999, 42:1033-49. 10.1007%2Fs001250051268","journal-title":"Diabetologia"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5483.1357","article-title":"PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma","volume":"289","author":"Kroll TG","year":"2000","unstructured":"Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma. Science. 2000, 289:1357-60. 10.1126\/science.289.5483.1357","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.02.004","article-title":"PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck","volume":"42","author":"Bishop JA","year":"2011","unstructured":"Bishop JA, Sharma R, Westra WH. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck. Hum Pathol. 2011, 42:1873-77. 10.1016\/j.humpath.2011.02.004","journal-title":"Hum Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011115)92:10<2529::aid-cncr1604>3.0.co;2-m","article-title":"Karyotypic characterization of papillary thyroid carcinomas","volume":"92","author":"Roque L","year":"2001","unstructured":"Roque L, Nunes VM, Ribeiro C, Martins C, Soares J. Karyotypic characterization of papillary thyroid carcinomas. Cancer. 2001, 92:2529-38. 10.1002\/1097-0142(20011115)92:10&lt;2529::aid-cncr1604&gt;3.0.co;2-m","journal-title":"Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11672-1","article-title":"PAX8 activates metabolic genes via enhancer elements in renal cell carcinoma","volume":"10","author":"Bleu M","year":"2019","unstructured":"Bleu M, Gaulis S, Lopes R, et al.. PAX8 activates metabolic genes via enhancer elements in renal cell carcinoma. Nat Commun. 2019, 10:3739. 10.1038\/s41467-019-11672-1","journal-title":"Nat Commun"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2014-202259","article-title":"PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?","volume":"68","author":"Barr ML","year":"2015","unstructured":"Barr ML, Jilaveanu LB, Camp RL, Adeniran AJ, Kluger HM, Shuch B. PAX-8 expression in renal tumours and distant sites: a useful marker of primary and metastatic renal cell carcinoma?. J Clin Pathol. 2015, 68:12-17. 10.1136\/jclinpath-2014-202259","journal-title":"J Clin Pathol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2011-200508","article-title":"PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody","volume":"65","author":"Hu Y","year":"2012","unstructured":"Hu Y, Hartmann A,  Stoehr C, et al.. PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody. J Clin Pathol. 2012, 65:254-56. 10.1136\/jclinpath-2011-200508","journal-title":"J Clin Pathol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study","volume":"19","author":"Tacha D","year":"2011","unstructured":"Tacha D, Zhou D, Cheng L. Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol. 2011, 19:293-99. 10.1097\/PAI.0b013e3182025f66","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan A","year":"2011","unstructured":"Ozcan A, Shen SS, Hamilton C, Anjana K, Coffey D, Krishnan B, Truong LD. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol. 2011, 24:751-64. 10.1038\/modpathol.2011.3","journal-title":"Mod Pathol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21590","article-title":"Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology","volume":"40","author":"Knoepp SM","year":"2012","unstructured":"Knoepp SM, Kunju LP, Roh MH. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology. Diagn Cytopathol. 2012, 40:667-72. 10.1002\/dc.21590","journal-title":"Diagn Cytopathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24768","article-title":"Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy","volume":"116","author":"Shuch B","year":"2010","unstructured":"Shuch B, Said J, LaRochelle JC, et al.. Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy. Cancer. 2010, 116:616-24. 10.1002\/cncr.24768","journal-title":"Cancer"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318299f12e","article-title":"Renal tumors: diagnostic and prognostic biomarkers","volume":"37","author":"Tan PH","year":"2013","unstructured":"Tan PH, Cheng L, Rioux-Leclercq N, et al.. Renal tumors: diagnostic and prognostic biomarkers. Am J Surg Pathol. 2013, 37:1518-31. 10.1097\/PAS.0b013e318299f12e","journal-title":"Am J Surg Pathol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0072-OA","article-title":"PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison","volume":"136","author":"Ozcan A","year":"2012","unstructured":"Ozcan A, de la Roza G, Ro JY, Shen SS, Truong LD. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. Arch Pathol Lab Med. 2012, 136:1541-51. 10.5858\/arpa.2012-0072-OA","journal-title":"Arch Pathol Lab Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.241","article-title":"Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer","volume":"107","author":"Mhawech-Fauceglia P","year":"2012","unstructured":"Mhawech-Fauceglia P, Wang D, Samrao D, Godoy H, Pejovic T, Liu S, Lele S. Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer. Br J Cancer. 2012, 107:370-74. 10.1038\/bjc.2012.241","journal-title":"Br J Cancer"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e31821ac6c3","article-title":"Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53","volume":"30","author":"Brunner AH","year":"2011","unstructured":"Brunner AH, Riss P, Heinze G, Meltzow E, Brustmann H. Immunoexpression of PAX 8 in endometrial cancer: relation to high-grade carcinoma and p53. Int J Gynecol Pathol. 2011, 30:569-75. 10.1097\/PGP.0b013e31821ac6c3","journal-title":"Int J Gynecol Pathol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e3182a54afa","article-title":"PAX8 expression in uterine adenocarcinomas and mesonephric proliferations","volume":"33","author":"Yemelyanova A","year":"2014","unstructured":"Yemelyanova A, Gown AM, Wu LS, Holmes BJ, Ronnett BM, Vang R. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol. 2014, 33:492-99. 10.1097\/PGP.0b013e3182a54afa","journal-title":"Int J Gynecol Pathol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3515","article-title":"PAX8 is transcribed aberrantly in cervical tumors and derived cell lines due to complex gene rearrangements","volume":"49","author":"L\u00f3pez-Urrutia E","year":"2016","unstructured":"L\u00f3pez-Urrutia E, Pedroza-Torres A, Fern\u00e1ndez-Retana J, et al.. PAX8 is transcribed aberrantly in cervical tumors and derived cell lines due to complex gene rearrangements. Int J Oncol. 2016, 49:371-80. 10.3892\/ijo.2016.3515","journal-title":"Int J Oncol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.190","article-title":"PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein","volume":"30","author":"Li CG","year":"2011","unstructured":"Li CG, Nyman JE, Braithwaite AW, Eccles MR. PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein. Oncogene. 2011, 30:4824-34. 10.1038\/onc.2011.190","journal-title":"Oncogene"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.047035","article-title":"Cells expressing PAX8 are the main source of homeostatic regeneration of adult mouse endometrial epithelium and give rise to serous endometrial carcinoma","volume":"13","author":"Fu DJ","year":"2020","unstructured":"Fu DJ, De Micheli AJ, Bidarimath M, Ellenson LH, Cosgrove BD, Flesken-Nikitin A, Nikitin AY. Cells expressing PAX8 are the main source of homeostatic regeneration of adult mouse endometrial epithelium and give rise to serous endometrial carcinoma. Dis Model Mech. 2020, 13:dmm047035. 10.1242\/dmm.047035","journal-title":"Dis Model Mech"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33614","article-title":"Association of genomic variants at PAX8 and PBX2 with cervical cancer risk","volume":"149","author":"Ramachandran D","year":"2021","unstructured":"Ramachandran D, Wang Y, Sch\u00fcrmann P, et al.. Association of genomic variants at PAX8 and PBX2 with cervical cancer risk. Int J Cancer. 2021, 149:893-900. 10.1002\/ijc.33614","journal-title":"Int J Cancer"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e318257df46","article-title":"PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia","volume":"32","author":"Shukla A","year":"2013","unstructured":"Shukla A, Thomas D, Roh MH. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia. Int J Gynecol Pathol. 2013, 32:116-21. 10.1097\/PGP.0b013e318257df46","journal-title":"Int J Gynecol Pathol"},{"key":"ref44","article-title":"A case of poorly differentiated adenocarcinoma of the uterine cervix treated with paclitaxel and carboplatin after positive PAX 8 immunostaining (article in Japanese)","volume":"40","author":"Maenaka T","year":"2013","unstructured":"Maenaka T, Iwata N, Egawa-Takata T, et al.. A case of poorly differentiated adenocarcinoma of the uterine cervix treated with paclitaxel and carboplatin after positive PAX 8 immunostaining (article in Japanese). Gan To Kagaku Ryoho. 2013, 40:1413-17.","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21426","article-title":"Pax8: a marker for carcinoma of M\u00fcllerian origin in serous effusions","volume":"39","author":"Tong GX","year":"2011","unstructured":"Tong GX, Devaraj K, Hamele-Bena D, et al.. Pax8: a marker for carcinoma of M\u00fcllerian origin in serous effusions. Diagn Cytopathol. 2011, 39:567-74. 10.1002\/dc.21426","journal-title":"Diagn Cytopathol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPUFNMEZ3MK1BK","article-title":"NY-BR-1 and PAX8 immunoreactivity in breast, gynecologic tract, and other CK7+ carcinomas: potential use for determining site of origin","volume":"136","author":"Woodard AH","year":"2011","unstructured":"Woodard AH, Yu J, Dabbs DJ, et al.. NY-BR-1 and PAX8 immunoreactivity in breast, gynecologic tract, and other CK7+ carcinomas: potential use for determining site of origin. Am J Clin Pathol. 2011, 136:428-35. 10.1309\/AJCPUFNMEZ3MK1BK","journal-title":"Am J Clin Pathol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.04.020","article-title":"The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions","volume":"130","author":"Danialan R","year":"2013","unstructured":"Danialan R, Assaad M, Burghardt J, Newcomb P, Cartun RW, Mandavilli S. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions. Gynecol Oncol. 2013, 130:383-88. 10.1016\/j.ygyno.2013.04.020","journal-title":"Gynecol Oncol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000102","article-title":"Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix","volume":"33","author":"Goyal A","year":"2014","unstructured":"Goyal A, Yang B. Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix. Int J Gynecol Pathol. 2014, 33:613-19. 10.1097\/PGP.0000000000000102","journal-title":"Int J Gynecol Pathol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0081-OA","article-title":"Assessment of the utility of PAX8 immunohistochemical stain in diagnosing endocervical glandular lesions","volume":"140","author":"Liang L","year":"2016","unstructured":"Liang L, Zheng W, Liu J, Liang SX. Assessment of the utility of PAX8 immunohistochemical stain in diagnosing endocervical glandular lesions. Arch Pathol Lab Med. 2016, 140:148-52. 10.5858\/arpa.2015-0081-OA","journal-title":"Arch Pathol Lab Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP4NSKW5TLGTDS","article-title":"Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (\u0394Np63) in squamous cell and urothelial carcinoma","volume":"140","author":"Gailey MP","year":"2013","unstructured":"Gailey MP, Bellizzi AM. Immunohistochemistry for the novel markers glypican 3, PAX8, and p40 (\u0394Np63) in squamous cell and urothelial carcinoma. Am J Clin Pathol. 2013, 140:872-80. 10.1309\/AJCP4NSKW5TLGTDS","journal-title":"Am J Clin Pathol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000309","article-title":"Comprehensive analysis of PAX8 expression in epithelial malignancies of the uterine cervix","volume":"36","author":"Wong S","year":"2017","unstructured":"Wong S, Hong W, Hui P, Buza N. Comprehensive analysis of PAX8 expression in epithelial malignancies of the uterine cervix. Int J Gynecol Pathol. 2017, 36:101-106. 10.1097\/PGP.0000000000000309","journal-title":"Int J Gynecol Pathol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31825cc8ee","article-title":"Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors","volume":"23","author":"Jones MW","year":"2013","unstructured":"Jones MW, Onisko A, Dabbs DJ, Elishaev E, Chiosea S, Bhargava R. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors. Int J Gynecol Cancer. 2013, 23:380-84. 10.1097\/IGC.0b013e31825cc8ee","journal-title":"Int J Gynecol Cancer"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed Z","year":"2019","unstructured":"Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019, 11:287-99. 10.2147\/IJWH.S197604","journal-title":"Int J Womens Health"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10080262","article-title":"UnPAXing the divergent roles of PAX2 and PAX8 in high-grade serous ovarian cancer","volume":"10","author":"Hardy LR","year":"2018","unstructured":"Hardy LR, Salvi A, Burdette JE. UnPAXing the divergent roles of PAX2 and PAX8 in high-grade serous ovarian cancer. Cancers (Basel). 2018, 10:262. 10.3390\/cancers10080262","journal-title":"Cancers (Basel)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-292","article-title":"A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells","volume":"14","author":"Di Palma T","year":"2014","unstructured":"Di Palma T, Lucci V, de Cristofaro T, Filippone MG, Zannini M. A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells. BMC Cancer. 2014, 14:292. 10.1186\/1471-2407-14-292","journal-title":"BMC Cancer"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1002\/dc.20643","article-title":"WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions","volume":"35","author":"Zhu W","year":"2007","unstructured":"Zhu W, Michael CW. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Diagn Cytopathol. 2007, 35:370-75. 10.1002\/dc.20643","journal-title":"Diagn Cytopathol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6949","article-title":"PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer","volume":"14","author":"Chai HJ","year":"2017","unstructured":"Chai HJ, Ren Q, Fan Q, et al.. PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer. Oncol Lett. 2017, 14:5871-75. 10.3892\/ol.2017.6949","journal-title":"Oncol Lett"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1309\/3PDN-PMT5-EQTM-H0CD","article-title":"Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases","volume":"114","author":"Moran CA","year":"2000","unstructured":"Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol. 2000, 114:100-10. 10.1309\/3PDN-PMT5-EQTM-H0CD","journal-title":"Am J Clin Pathol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S109693","article-title":"Invasive atypical thymic carcinoid: three case reports and literature review","volume":"9","author":"Zhu S","year":"2016","unstructured":"Zhu S, Wang ZT, Liu WZ, Zong SX, Li BS.  Invasive atypical thymic carcinoid: three case reports and literature review. Onco Targets Ther. 2016, 9:6171-76. 10.2147\/OTT.S109693","journal-title":"Onco Targets Ther"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.111","article-title":"Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1","volume":"26","author":"Weissferdt A","year":"2013","unstructured":"Weissferdt A, Tang X, Wistuba II, Moran CA. Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1. Mod Pathol. 2013, 26:1554-60. 10.1038\/modpathol.2013.111","journal-title":"Mod Pathol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182260735","article-title":"Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis","volume":"35","author":"Weissferdt A","year":"2011","unstructured":"Weissferdt A, Moran CA. Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis. Am J Surg Pathol. 2011, 35:1305-10. 10.1097\/PAS.0b013e3182260735","journal-title":"Am J Surg Pathol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e318297cdb5","article-title":"Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma","volume":"22","author":"Asirvatham JR","year":"2014","unstructured":"Asirvatham JR, Esposito MJ, Bhuiya TA. Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma. Appl Immunohistochem Mol Morphol. 2014, 22:372-76. 10.1097\/PAI.0b013e318297cdb5","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2018.0106","article-title":"The interdisciplinary diagnosis and treatment of intraocular tumors","volume":"115","author":"Bornfeld N","year":"2018","unstructured":"Bornfeld N, Biewald E, Bauer S, Temming P, Lohmann D, Zeschnigk M. The interdisciplinary diagnosis and treatment of intraocular tumors. Dtsch Arztebl Int. 2018, 115:106-11. 10.3238\/arztebl.2018.0106","journal-title":"Dtsch Arztebl Int"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.09.033","article-title":"Usefulness of PAX8 immunohistochemistry in adult intraocular tumor diagnosis","volume":"128","author":"Mudhar HS","year":"2021","unstructured":"Mudhar HS, Milman T, Eagle RC Jr, et al.. Usefulness of PAX8 immunohistochemistry in adult intraocular tumor diagnosis. Ophthalmology. 2021, 128:765-78. 10.1016\/j.ophtha.2020.09.033","journal-title":"Ophthalmology"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqy090.119","article-title":"PAX-8 expression in retinoblastoma and the eyes of human embryos","volume":"150","author":"Appleford C","year":"2018","unstructured":"Appleford C, Zhang P. PAX-8 expression in retinoblastoma and the eyes of human embryos. Am J Clin Pathol. 2018, 150:48-49. 10.1093\/ajcp\/aqy090.119","journal-title":"Am J Clin Pathol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2021.100024","article-title":"PAX8 expression in the crystalline lens and lens-derived lesions","volume":"1","author":"Milman T","year":"2021","unstructured":"Milman T, Mudhar HS, Eagle RC Jr. PAX8 expression in the crystalline lens and lens-derived lesions. Ophthalmol Sci. 2021, 1:100024. 10.1016\/j.xops.2021.100024","journal-title":"Ophthalmol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66653-paired-box-gene-8-pax8-and-its-association-with-epithelial-carcinomas","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:53Z","timestamp":1707507233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66653-paired-box-gene-8-pax8-and-its-association-with-epithelial-carcinomas"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":66,"URL":"https:\/\/doi.org\/10.7759\/cureus.17208","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,16]]}}}